Hareton Teixeira Vechi Lucas Rodrigues Maia Manoela do Monte Alves João Firmino Rodrigues-Neto
10.1590/S1678-9946202062102
Rev Inst Med Trop Sao Paulo
2020 Dec 18;62:e102.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33331521/
Adalimumab / therapeutic use COVID-19 Crohn Disease / drug therapy Prednisone / therapeutic use
Adalimumab / therapeutic use COVID-19 Crohn Disease / drug therapy Prednisone / therapeutic use Case Reports Crohn Disease / virology Female Humans Tumor Necrosis Factor Inhibitors / therapeutic use Tumor Necrosis Factor Inhibitors Adalimumab Prednisone
PMC7748034
33331521
Favorable outcome of COVID-19 in a young woman with severe Crohn's disease on regular use of adalimumab and prednisone: a case report
2020